{"id":473,"date":"2012-04-08T21:22:56","date_gmt":"2012-04-08T21:22:56","guid":{"rendered":"http:\/\/ksfe-ev.de\/cms\/?page_id=473"},"modified":"2014-07-25T21:26:47","modified_gmt":"2014-07-25T21:26:47","slug":"poster-2","status":"publish","type":"page","link":"https:\/\/ksfe-ev.de\/cms\/archiv\/poster-2\/","title":{"rendered":"Poster"},"content":{"rendered":"<table>\n<tbody>\n<tr>\n<td>Posterpr\u00e4sentation<\/td>\n<\/tr>\n<tr>\n<td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<table>\n<tbody>\n<tr>\n<td align=\"left\" valign=\"top\">Die Autoren erl\u00e4utern und diskutieren die Inhalte Donnerstag, den 5. M\u00e4rz um 13:30 mit Interessenten direkt bei ihren Postern.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<hr width=\"80%\" \/>\n<p>&nbsp;<\/p>\n<table>\n<colgroup>\n<col width=\"15%\" \/>\n<col width=\"70%\" \/>\n<col width=\"15%\" \/> <\/colgroup>\n<tbody>\n<tr>\n<td><\/td>\n<td align=\"left\" valign=\"top\" bgcolor=\"#e9edf5\"><em>A. Ring <sup>1)<\/sup>, K. Kupas <sup>2)<\/sup>,<\/em><br \/>\n<sup>1)<\/sup> Phase I\/II Biostatistics, Boehringer Ingelheim Pharma GmbH &amp; Co. KG<br \/>\n<sup>2)<\/sup> Omega Mediation Clinical Research Services GmbH &amp; Co KG, Germany<a><\/p>\n<p><img decoding=\"async\" src=\"http:\/\/www.ksfe2009.uni-halle.de\/To.gif\" alt=\"\" width=\"7\" align=\"middle\" border=\"0\" \/>\u00a0Vergleich parametrischer und nichtparametrischer Verfahren zur Sch\u00e4tzung der Zeit bis zum Erreichen des &#8222;steady states&#8220; in klinischen Studien mit Mehrfachgabe<\/a><\/td>\n<td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<hr width=\"80%\" \/>\n<p>&nbsp;<\/p>\n<table>\n<colgroup>\n<col width=\"15%\" \/>\n<col width=\"70%\" \/>\n<col width=\"15%\" \/> <\/colgroup>\n<tbody>\n<tr>\n<td><\/td>\n<td align=\"left\" valign=\"top\" bgcolor=\"#e9edf5\"><em>M. Kunze <sup>1)<\/sup>, K. Lehmann <sup>1)<\/sup>, L. Minning <sup>1)<\/sup>, Y. Ronningen <sup>2)<\/sup>, J. Haerting <sup>1)<\/sup><\/em><br \/>\n<sup>1)<\/sup> Institut f\u00fcr medizinische Epidemiologie, Biometrie und Informatik,<br \/>\nMartin-Luther-Universit\u00e4t Halle-Wittenberg<br \/>\n<sup>2)<\/sup> Koordinierungszentrum f\u00fcr klinische Studien,<br \/>\nMartin-Luther-Universit\u00e4t Halle-Wittenberg<a><\/p>\n<p><img decoding=\"async\" src=\"http:\/\/www.ksfe2009.uni-halle.de\/To.gif\" alt=\"\" width=\"7\" align=\"middle\" border=\"0\" \/>\u00a0Datentransfer ohne Informationsverlust von MS Access nach SAS<\/a><\/td>\n<td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<hr width=\"80%\" \/>\n<p>&nbsp;<\/p>\n<table>\n<colgroup>\n<col width=\"15%\" \/>\n<col width=\"70%\" \/>\n<col width=\"15%\" \/> <\/colgroup>\n<tbody>\n<tr>\n<td><\/td>\n<td align=\"left\" valign=\"top\" bgcolor=\"#e9edf5\"><em>R. Muche, S. Kocak, B. Einsiedler,<\/em><br \/>\nInstitut f\u00fcr Biometrie,<br \/>\nUniversit\u00e4t Ulm<a><\/p>\n<p><img decoding=\"async\" src=\"http:\/\/www.ksfe2009.uni-halle.de\/To.gif\" alt=\"\" width=\"7\" align=\"middle\" border=\"0\" \/>\u00a0Automatisierte Unterst\u00fctzung f\u00fcr Pr\u00fcfungen in Statistiksoftwarekursen im Humanmedizinstudium<\/a><\/td>\n<td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<hr width=\"80%\" \/>\n<p>&nbsp;<\/p>\n<table>\n<colgroup>\n<col width=\"15%\" \/>\n<col width=\"70%\" \/>\n<col width=\"15%\" \/> <\/colgroup>\n<tbody>\n<tr>\n<td><\/td>\n<td align=\"left\" valign=\"top\" bgcolor=\"#e9edf5\"><em>R. Muche, B. Janz, B. Einsiedler,<\/em><br \/>\nInstitut f\u00fcr Biometrie,<br \/>\nUniversit\u00e4t Ulm<a><\/p>\n<p><img decoding=\"async\" src=\"http:\/\/www.ksfe2009.uni-halle.de\/To.gif\" alt=\"\" width=\"7\" align=\"middle\" border=\"0\" \/>\u00a0Quantitative Analysen medizinischer Pr\u00fcfungen mittels eines (teil-) automatisierten SAS-Programms<\/a><\/td>\n<td><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Posterpr\u00e4sentation Die Autoren erl\u00e4utern und diskutieren die Inhalte Donnerstag, den 5. M\u00e4rz um 13:30 mit Interessenten direkt bei ihren Postern. &nbsp; &nbsp; A. Ring 1), K. Kupas 2), 1) Phase I\/II Biostatistics, Boehringer Ingelheim Pharma GmbH &amp; Co. KG 2) &hellip; <a href=\"https:\/\/ksfe-ev.de\/cms\/archiv\/poster-2\/\">Weiterlesen <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":38,"menu_order":8,"comment_status":"closed","ping_status":"closed","template":"sidebar-page.php","meta":[],"_links":{"self":[{"href":"https:\/\/ksfe-ev.de\/cms\/wp-json\/wp\/v2\/pages\/473"}],"collection":[{"href":"https:\/\/ksfe-ev.de\/cms\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ksfe-ev.de\/cms\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ksfe-ev.de\/cms\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ksfe-ev.de\/cms\/wp-json\/wp\/v2\/comments?post=473"}],"version-history":[{"count":2,"href":"https:\/\/ksfe-ev.de\/cms\/wp-json\/wp\/v2\/pages\/473\/revisions"}],"predecessor-version":[{"id":602,"href":"https:\/\/ksfe-ev.de\/cms\/wp-json\/wp\/v2\/pages\/473\/revisions\/602"}],"up":[{"embeddable":true,"href":"https:\/\/ksfe-ev.de\/cms\/wp-json\/wp\/v2\/pages\/38"}],"wp:attachment":[{"href":"https:\/\/ksfe-ev.de\/cms\/wp-json\/wp\/v2\/media?parent=473"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}